Skip to main content

Advertisement

SpringerLink
Log in

Serum transforming growth factor-β1 levels and pancreatic cancer risk: a nested case–control study (Japan)

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective

To examine the relationship of baseline levels of serum TGF-β1 to the subsequent risk of death from pancreatic cancer in a nested case–control study.

Methods

The cases were 85 persons who had provided a blood sample at baseline and subsequently died of pancreatic cancer during the study period. For each case, three controls were randomly selected from among the cohort participants, and were matched for each case by sex, age (±1 year), and study area. Serum TGF-β1 levels were measured with enzyme-linked immunosorbent assay (ELISA). Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated from conditional logistic models.

Results

The mean of serum TGF-β1 levels was significantly higher among cases than among controls (p = 0.01). Individuals with serum TGF-β1 levels in the highest quartile had a 2.5-fold increase in risk as compared with those in the lowest quartile (OR, 2.5; 95% CI, 0.9–6.9), after adjustment for month of blood draw, cigarette smoking, body mass index and history of diabetes. Excluding 12 pancreatic cancer deaths that occurred within three years of follow-up did not alter the positive association.

Conclusion

Our prospective data indicate that high serum TGF-β1 levels may be associated with an increased risk of death from pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Statistics and Information Department, Minister’s Secretariat. Vital Statistics of Japan (2003) Ministry of Health and Welfare, Tokyo

  2. Lin Y, Tamakoshi A, Wakai K, et al (1998) Descriptive epidemiology of pancreatic cancer in Japan. J Epidemiol 8:52–59

    PubMed  CAS  Google Scholar 

  3. Lin Y, Tamakoshi A, Kawamura T, et al (2001) An epidemiological overview of environmental and genetic risk factors of pancreatic cancer. Asian Pac J Cancer Prev 2:271–280

    PubMed  Google Scholar 

  4. Koopmann J, Buckhaults P, Brown DA, et al (2004) Serum macrophage inhibitor cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res 10:2386–2392

    Article  PubMed  CAS  Google Scholar 

  5. Koopmann J, Zhang Z, White N, et al (2004) Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 10:860–868

    Article  PubMed  CAS  Google Scholar 

  6. Korc M (1998) Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am 7:25–41

    PubMed  CAS  Google Scholar 

  7. Ivanovic V, Melman A, Davis-Joseph B, Valcic M, Geliebter J (1995) Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer. Nat Med 1:282–284

    Article  PubMed  CAS  Google Scholar 

  8. Shim KS, Kim KH, Han WS, Park EB (1999) Elevated serum levels of transforming growth factor-β1 in patients with colorectal carcinoma. Cancer 85:554–561

    Article  PubMed  CAS  Google Scholar 

  9. Sheen-Chen SM, Chen HS, Sheen CW, Eng HL, Chen WJ (2001) Serum levels of transforming growth factor β1 in patients with breast cancer. Arch Surg 136:937–940

    Article  PubMed  CAS  Google Scholar 

  10. Kleeff J, Friess H, Simon P, et al (1999) Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer. Dig Dis Sci 44:1793–1802

    Article  PubMed  CAS  Google Scholar 

  11. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor β in human disease. New Engl J Med 342:1350–1358

    Article  PubMed  CAS  Google Scholar 

  12. Derynck R, Akhurst RJ, Balmain A (2001) TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29:117–129

    Article  PubMed  CAS  Google Scholar 

  13. Massague J, Blain SW, Lo RS (2000) TGF-β signaling in growth control, cancer, and heritable disorders. Cell 103:295–309

    Article  PubMed  CAS  Google Scholar 

  14. Heldin CH, Miyazono K, tenDijke P (1997) TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465–471

    Article  PubMed  CAS  Google Scholar 

  15. Ohno Y, Tamakoshi A, and the JACC Study Group (2001) Japan Collaborative Study for Evaluation of Cancer Risk (JACC Study). J Epidemiol 11:144–150

    Google Scholar 

  16. Mantel N (1963) Chi-square tests with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58:690–700

    Article  Google Scholar 

  17. Piek E, Roberts AB (2001) Suppressor and oncogenic roles of transforming growth factor-β and its signaling pathways in tumorigenesis. Adv Cancer Res 83:1–54

    Article  PubMed  CAS  Google Scholar 

  18. Hahn SA, Schutte M, Hoque AT, et al (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350–353

    PubMed  CAS  Google Scholar 

  19. Esmatjes E, Flores L, Lario S, et al (1999) Smoking increases serum levels of transforming growth factor-β in diabetic patients. Diabetes Care 22:1915–1916

    PubMed  CAS  Google Scholar 

  20. Flores L, Vidal M, Abian J, et al (2004) The effects of smoking and its cessation on 8-epi-PGF2alpha and transforming growth factor-beta 1 in Type 1 diabetes mellitus. Diabet Med 21:285–289

    Article  PubMed  CAS  Google Scholar 

  21. Ryder MI, Saghizadeh M, Ding Y, Nguyen N, Soskolne A (2002) Effects of tobacco smoke on the secretion of interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta from peripheral blood mononuclear cells. Oral Microbiol Immunol 17:331–336

    Article  PubMed  CAS  Google Scholar 

  22. Cucina A, Corvino V, Sapienza P, et al (1999) Nicotine regulates basic fibroblastic growth factor and transforming growth factor beta1 production in endothelial cells. Biochem Biophys Res Commun 13:306–312

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank Dr. Kunio Aoki, Professor Emeritus, Nagoya University School of Medicine and the former chairman of the JACC Study Group, and Dr. Haruo Sugano, the former Director of the Cancer Institute of the Japanese Foundation for Cancer Research, for their great contribution to the initiation of the JACC study.

The present investigators involved in the JACC Study and their affiliations are as follows: Akiko Tamakoshi (chairman of the study group), Nagoya University Graduate School of Medicine; Dr. M. Mori, Sapporo Medical University School of Medicine; Dr. Y. Motohashi, Akita University School of Medicine; Dr. I. Tsuji, Tohoku University Graduate School of Medicine; Dr. Y. Nakamura, Jichi Medical School; Dr. H. Iso, Institute of Community Medicine, University of Tsukuba; Dr. H. Mikami, Chiba Cancer Center; Dr. S. Hashimoto, Fujita Health University School of Medicine; Dr. Y. Inaba, Juntendo University School of Medicine; Dr. Y. Hoshiyama, Showa University School of Medicine; Dr. H. Suzuki, Niigata University Graduated School of Medicine and Dental Science; Dr. H. Shimizu, Gifu University School of Medicine; Dr. H. Toyoshima, Nagoya University Graduated School of Medicine; Dr. S. Tokudome, Nagoya City University Graduated School of Medicine; Dr. Y. Ito, Fujita Health University School of Health Sciences; Dr. S. Kikuchi, Aichi Medical University School of Medicine; Dr. A. Koizumi, Graduate School of Medicine and Faculty of Medicine, Kyoto University; Dr. T. Kawamura, Kyoto University Center for Student Health; Dr. Y. Watanabe, Kyoto Prefectural University of Medicine, Research Institute for Neurological Diseases and Geriatrics; Dr. T. Miki, Kyoto Prefectural University of Medicine; Dr. C. Date, Faculty of Human Environmental Sciences, Mukogawa Women’s University; Dr. K. Sakata, Wakayama Medical University; Dr. T. Nose, Tottori University Faculty of Medicine; Dr. N. Hayakawa, Research Institute for Radiation Biology and Medicine, Hiroshima University; Dr. T. Yoshimura, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan; Dr. K. Fukuda, Kurume University School of Medicine; Dr. N. Okamoto, Kanagawa Cancer Center; Dr. T. Ishibashi, Asama General Hospital; Dr. H. Shio, Shiga Medical Center, Dr. Y. Ohno, Asahi Rosai Hosipital and Dr. K. Tajima, Aichi Cancer Center Research Institute. The former investigators involved in the JACC study and their affiliations are as follows: Dr. K. Aoki, Aichi Cancer Center; Dr. S. Tominaga, Aichi Cancer Center Research Institute; Dr. S. Anzai, Dr. T. Kawaguchi, Dr. K. Nakamura, Dr. M. Masaki, Showa University School of Medicine; Dr. S. Kanamori, Dr. M. Morimoto, Dr. S. Yoshimura, Shiga Medical Center for Adults; Dr. S. Kamiyama, Dr. Y. Takizawa, Dr. N. Hachiya, Akita University School of Medicine; Dr. K. Kawai, Dr. S. Nakagawa, Dr. H. Watanabe, Kyoto Prefectural University of Medicine; Dr. M. Kurihara, Research Institute for Radiation Biology and Medicine, Hiroshima University; Dr. Y. Komachi, Institute of Community Medicine, University of Tsukuba; Dr. R. Sasaki, Aichi Medical University; Dr. M. Sugita, Toho University School of Medicine; Dr. I. Sugimura, Asahikawa Kosei Hospital; Dr. T. Tanaka, Chigasaki Public Health Center; Dr. T. Hirohata, Kyushu University School of Medicine; Dr. I. Fujimoto, Center for Adult Diseases, Osaka; Dr. M. Matsuzaki, Chigasaki Public Health and Welfare Center; Dr. H. Miyake, Sapporo Medical University School of Medicine; Dr. M. Murata, Chiba Cancer Center; Dr. S. Morio, Kanagawa Cancer Center; Dr. H. Yanagawa, Jichi Medical School and Dr. S. Watanabe, Tokyo University of Agriculture.

This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas (C) (2) (No.13220019) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The JACC Study has also been supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 61010076, 62010074, 63010074, 1010068, 2151065, 3151064, 4151063, 5151069, 6279102 and 11181101).

Author information

Authors and Affiliations

  1. Department of Public Health, Aichi Medical University School of Medicine, 21 Karimata, Yazako, Nagakute-cho, Aichi-gun, Aichi, 480-1195, Japan

    Yingsong Lin, Shogo Kikuchi, Yuki Obata & Kiyoko Yagyu

  2. Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Akiko Tamakoshi

  3. Department of Epidemiology and Environmental Health, Juntendo University School of Medicine, Tokyo, Japan

    Yutaka Inaba & Michiko Kurosawa

  4. Center for Student Health, Kyoto University, Kyoto, Japan

    Takashi Kawamura

  5. Department of Public health, Akita University School of Medicine, Akita, Japan

    Yutaka Motohashi

  6. Asama General Hospital, Nagano, Japan

    Teruo Ishibashi

Authors
  1. Yingsong Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shogo Kikuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akiko Tamakoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuki Obata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kiyoko Yagyu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yutaka Inaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michiko Kurosawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takashi Kawamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yutaka Motohashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Teruo Ishibashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the JACC Study Group

Corresponding author

Correspondence to Shogo Kikuchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, Y., Kikuchi, S., Tamakoshi, A. et al. Serum transforming growth factor-β1 levels and pancreatic cancer risk: a nested case–control study (Japan). Cancer Causes Control 17, 1077–1082 (2006). https://doi.org/10.1007/s10552-006-0048-0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-006-0048-0

Keywords

Search

Navigation